Finance

Beta
Lists
CRIS:NASDAQ
Curis Inc
$0.32
+55.98%
(+0.12) 1D
$0.29
-9.66% (-0.031)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRIS...
Open
$0.21
High
$0.38
Low
$0.21
Mkt. cap
12.26M
Avg. vol.
586.02K
Volume
109.83M
52-wk high
$2.48
52-wk low
$0.18
EPS
-$1.20
Beta
3.05
Shares outstanding
38.98M
No. of employees
22
Open
$0.21
High
$0.38
Low
$0.21
Mkt. cap
12.26M
Avg. vol.
586.02K
Volume
109.83M
52-wk high
$2.48
52-wk low
$0.18
EPS
-$1.20
Beta
3.05
Shares outstanding
38.98M
No. of employees
22
News stories
From sources across the web
About Curis Inc
CEO-
Employees22
Founded2000
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitecuris.com
Analyst ratings
Based on 2 analysts giving stock ratings to CRIS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CRIS in the last 3 months.
Highest
Current $0.32
$17.00 (+5,195.95%)
Average
$11.00 (+3,326.79%)
Lowest
$5.00 (+1,457.63%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sara Nik
H.C. Wainwright
Buy
Reiterated
$17.00
+5,196%
06/26/2026
Boris Peaker
JonesTrading
Buy
Maintained
$5.00
+1,457.6%
05/13/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
-
-
03/23/2026
Soumit Roy
JonesTrading
Buy
Maintained
$5.00
+1,457.6%
12/09/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.75M
3.18M
1.14M
-
Cost of goods sold
7.06M
6.09M
7.00M
6.45M
Cost of revenue
7.06M
6.09M
7.00M
6.45M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.94M
4.01M
1.71M
5.07M
Operating expense
3.94M
4.01M
1.71M
5.07M
Total operating expenses
11.00M
10.10M
8.71M
11.52M
Operating income
-8.25M
-6.92M
-7.57M
-11.52M
Other non operating income
-
-
-
-12.68M
EBT including unusual items
-8.59M
-7.73M
19.36M
-24.20M
EBT excluding unusual items
-8.59M
-7.73M
-7.83M
-24.20M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.59M
-7.73M
19.36M
-24.20M
Net profit margin
-312.59%
-243.36%
1,700.88%
-
Earnings per share
-0.68
-0.49
-0.50
-1.25
Interest and investment income
92.00K
80.00K
51.00K
-
Interest expense
-434.00K
-885.00K
-314.00K
-
Net interest expenses
-342.00K
-805.00K
-263.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.21M
-6.89M
-7.53M
-11.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CRIS
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer